41 results
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
and Treatment Algorithm ... Diagnosis: Ferritin ... Guidelines: • ACC ... iron #deficiency #CHF ... algorithm #cardiology #treatment
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Heart Failure (CHF ... Exercise capacity Diagnosis ... depot iron] Treatment ... Heart #Failure #CHF ... #pharmacology #
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... recommended by the ACC ... /ambcarerx #CHF ... #HFrEF #Pharmacology ... #Management #Treatment
Hyperviscosity Syndrome - Causes and Treatment

 - Waldenstrom macroglobulinemia (most common) / Plasmapheresis 
 - Multiple
Syndrome - Causes and Treatment ... hyperleukocytosis (AML ... Phlebotomy - MH/CCF ... #Differential #Diagnosis ... #Treatment #Management
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... therapy is non-pharmacologic ... If patients using ... If all topical products ... Dermatitis #Topical #Treatment
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
and iron release Diagnosis ... functional ID) Treatment ... composite endpoint of all-cause ... iron #deficiency #CHF ... #heartfailure #diagnosis
In order to better classify heart failure, the American College of Cardiology Foundation and the American
one direction using ... With treatment, ... patients with a diagnosis ... #Diagnosis #Cardiology ... #CHF #Congestive
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
un lymphatic Diagnostic ... endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... #heartfailure #diagnosis ... management #cardiology #pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
complete paralysis of all ... Guillain-Barre Diagnosis ... Treatment: • Plasmapheresis ... Barre #Syndrome #diagnosis ... #management #treatment
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... oral suspension DOSING ... patients with CKD, HF ... ACE inhibitors, ... #Hyperkalemia #Pharmacology